Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 1
2006 1
2009 1
2013 1
2014 4
2015 3
2016 10
2017 9
2018 4
2019 8
2020 8
2021 11
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Norsworthy KJ, Mulkey F, Scott EC, Ward AF, Przepiorka D, Charlab R, Dorff SE, Deisseroth A, Kazandjian D, Sridhara R, Beaver JA, Farrell AT, de Claro RA, Pazdur R. Norsworthy KJ, et al. Among authors: kazandjian d. Clin Cancer Res. 2020 Aug 15;26(16):4280-4288. doi: 10.1158/1078-0432.CCR-20-0834. Epub 2020 May 11. Clin Cancer Res. 2020. PMID: 32393603 Free PMC article.
Diagnosed with myeloma before age 40.
Landgren O, Kazandjian D. Landgren O, et al. Among authors: kazandjian d. Blood. 2021 Dec 23;138(25):2601-2602. doi: 10.1182/blood.2021013539. Blood. 2021. PMID: 34940818 Free PMC article. No abstract available.
Second malignancies in multiple myeloma; emerging patterns and future directions.
Maclachlan K, Diamond B, Maura F, Hillengass J, Turesson I, Landgren CO, Kazandjian D. Maclachlan K, et al. Among authors: kazandjian d. Best Pract Res Clin Haematol. 2020 Mar;33(1):101144. doi: 10.1016/j.beha.2020.101144. Epub 2020 Jan 11. Best Pract Res Clin Haematol. 2020. PMID: 32139010 Free PMC article. Review.
The mutagenic impact of melphalan in multiple myeloma.
Maura F, Weinhold N, Diamond B, Kazandjian D, Rasche L, Morgan G, Landgren O. Maura F, et al. Among authors: kazandjian d. Leukemia. 2021 Aug;35(8):2145-2150. doi: 10.1038/s41375-021-01293-3. Epub 2021 May 19. Leukemia. 2021. PMID: 34012133 Review.
Clinician Perspectives on Current Issues in Lung Cancer Drug Development.
Waqar SN, Bonomi PD, Govindan R, Hirsch FR, Riely GJ, Papadimitrakopoulou V, Kazandjian D, Khozin S, Larkins E, Dickson DJ, Malik S, Horn L, Ferris A, Shaw AT, Jänne PA, Mok TS, Herbst R, Keegan P, Pazdur R, Blumenthal GM. Waqar SN, et al. Among authors: kazandjian d. J Thorac Oncol. 2016 Sep;11(9):1387-96. doi: 10.1016/j.jtho.2016.05.009. Epub 2016 Jul 9. J Thorac Oncol. 2016. PMID: 27401214 Free PMC article. Review.
58 results